Staging laparotomy with splenectomy in Hodgkin's disease

Area of Science:

• Oncology
• Surgical Pathology
• Clinical Medicine

Background:

• Hodgkin's disease staging is crucial for effective treatment planning.
• The role of staging laparotomy with splenectomy in evaluating abdominal involvement requires precise definition.

Purpose of the Study:

• To assess the diagnostic yield and therapeutic implications of staging laparotomy with splenectomy in Hodgkin's disease patients.
• To evaluate the impact of surgical staging on treatment modifications and patient outcomes.

Main Methods:

• Retrospective analysis of 91 Hodgkin's disease patients undergoing staging laparotomy with splenectomy between 1971-1976.
• Evaluation of abdominal lymph node, spleen, and liver involvement, alongside follow-up data to assess therapeutic changes and complications.

Main Results:

• Abdominal lymph node positivity was observed in 29% of patients, spleen positivity in 37%, and liver positivity in 10%.
• Staging laparotomy influenced treatment in 41% of patients (31% by stage change, 10% by radiation port modification).
• Sampling error was minimal; only 5 minor surgical complications and zero mortality were reported.

Conclusions:

• Staging laparotomy with splenectomy is a valuable tool for accurate Hodgkin's disease staging, identifying significant abdominal involvement.
• The procedure directly impacts therapeutic decisions, leading to improved treatment strategies and patient management.
• Surgical staging is safe and effective, with a high benefit rate and negligible complication risk in this patient cohort.